Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know
Alexandra Toste;
Rev Port Cardiol. 2022;41:499-509
Dapagliflozin alleviates isoprenaline-induced cardiac hypertrophy by promoting mitophagy via AMPK¿2 signaling pathway
Yue Feng; Zixiong Zhu; Xin Jing; Yibo Zhang; Yubin He; Xuewen Li;
Rev Port Cardiol. 2025;44:673-87
Quality of life score association with other patient-reported outcomes: Validating Minnesota Living with Heart Failure Questionnaire to Portuguese
Irene Marques; Sofia Viamonte; Milton Severo; António Gomes Pinto; Cândida Fonseca; Henrique Cyrne Carvalho;
Rev Port Cardiol. 2025;44:607-18